Sign In
Buy LNTH
$102.82
+2.57 (+2.56%)
At Close: Jun 04, 2026
The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked
12:00am, Wednesday, 17'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hour.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 16)
ADC Therapeutics SA (NYSE:...
Lantheus : Stockholders Approve Share Issuance For Merger with Progenics | MarketScreener
08:07pm, Tuesday, 16'th Jun 2020Lantheus Stockholders Approve Share Issuance For Merger with Progenics
08:05pm, Tuesday, 16'th Jun 2020
Lantheus Holdings, Inc. (NASDAQ: LNTH) ("Lantheus" or the "Company"), parent company of Lantheus Medical Imaging, Inc. ("LMI"), a leader in the development, manufacture and commercialization of innova
Lantheus : to Present at the BMO 2020 Prescriptions for Success Virtual Healthcare Conference | MarketScreener
12:31pm, Tuesday, 16'th Jun 2020Lantheus Holdings to Present at the BMO 2020 Prescriptions for Success Virtual Healthcare Conference
12:30pm, Tuesday, 16'th Jun 2020
Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovativ
Principal Financial Group Inc. Lowers Holdings in Lantheus Holdings Inc (NASDAQ:LNTH)
08:26am, Tuesday, 16'th Jun 2020
Principal Financial Group Inc. trimmed its position in Lantheus Holdings Inc (NASDAQ:LNTH) by 3.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 312,935 shares of
Lantheus Holdings to Present at the BMO 2020 Prescriptions for Success Virtual Healthcare Conference
12:00am, Tuesday, 16'th Jun 2020
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the developme
SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.
11:53pm, Wednesday, 27'th May 2020
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Progenics Pharmaceuticals, Inc. ("Progenics" or the "Company") (NASDAQ: PGNX)
Lantheus : to Present at the Jefferies Virtual Healthcare Conference | MarketScreener
08:32pm, Wednesday, 20'th May 2020Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference
08:30pm, Wednesday, 20'th May 2020
Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovativ
Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference
12:00am, Wednesday, 20'th May 2020
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the developme
Lantheus : to Present at the UBS Virtual Global Healthcare Conference | MarketScreener
08:32pm, Tuesday, 05'th May 2020Lantheus Holdings to Present at the UBS Virtual Global Healthcare Conference
08:30pm, Tuesday, 05'th May 2020
Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovativ
U.S. RESEARCH ROUNDUP-Berkshire Hathaway, DHT Holdings, Novo Nordisk
06:06pm, Monday, 04'th May 2020
Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies, including Berkshire Hathaway, DHT Holdings and Novo Nordisk, on Monday.
HIGHLIGHTS
